| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/11/2001 | EP1090114A2 Structured antisense nucleic acid molecules |
| 04/11/2001 | EP1090112A1 Human arf-related proteins |
| 04/11/2001 | EP1090110A2 Human vault rna |
| 04/11/2001 | EP1090039A1 Peptide composition as immunogen for the treatment of allergy |
| 04/11/2001 | EP1090034A2 Novel staphylococcus peptides for bacterial interference |
| 04/11/2001 | EP1090032A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 04/11/2001 | EP1090031A1 Substituted cyclooctadepsipeptides |
| 04/11/2001 | EP1090030A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 04/11/2001 | EP1090026A1 Diacylglycerol o-acyltransferase |
| 04/11/2001 | EP1090025A1 Antisense modulation of tnfr1 expression |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089764A2 A method for stimulating the immune system |
| 04/11/2001 | EP1089762A1 Konjugat |
| 04/11/2001 | EP1089757A1 Hla binding peptides and their uses |
| 04/11/2001 | EP1089756A1 CORRELATIVE PROTECTION USING OspA ANTIBODY TITERS |
| 04/11/2001 | EP1089755A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 04/11/2001 | EP1089754A2 An antimicrobial effective against gram-positive pathogens |
| 04/11/2001 | EP1089753A2 Use of a dipeptide for stimulating repair processes |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089751A1 Adjuvant therapy |
| 04/11/2001 | EP1089750A1 Compositions and methods for inhibiting bone resorption |
| 04/11/2001 | EP1089736A2 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 04/11/2001 | EP1089732A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089718A1 Sticking plaster for controlled release of natural interferon |
| 04/11/2001 | EP1089714A2 Processes to generate submicron particles of water-insoluble compounds |
| 04/11/2001 | EP1089712A2 Large porous particles emitted from an inhaler |
| 04/11/2001 | EP0963203A4 Mammalian tolloid-like gene and protein |
| 04/11/2001 | EP0900282A4 Ob receptor isoforms and nucleic acids encoding them |
| 04/11/2001 | EP0866704B1 Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 04/11/2001 | EP0800585B1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 04/11/2001 | EP0750506B1 Broad spectrum antimicrobial compounds and methods of use |
| 04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 04/11/2001 | EP0517829B1 Improved chimeric toxins |
| 04/11/2001 | CN1291235A Vaccines immunotherapeutics and method for using the same |
| 04/11/2001 | CN1291233A Human complement (3-degrading proteinase from i (streptococcus pheumoniae) |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291230A Biotin-binding receptor molecules |
| 04/11/2001 | CN1291198A Three-dimesional structures and models of Fc receptors and use thereof |
| 04/11/2001 | CN1291197A Novel acetamide derivative and use thereof |
| 04/11/2001 | CN1291107A Skin cave compositions |
| 04/11/2001 | CN1291106A Novel preventives/remedies for immunopathy |
| 04/11/2001 | CN1291104A A pharmaceutical preparation comprising an angiotension II2 type receptor agonist, and use thereof |
| 04/11/2001 | CN1291101A Regulation of estrus and ovulation in gilts |
| 04/11/2001 | CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 04/10/2001 | US6215041 Introducing non-human mammalian donor cell nucleus into no-human mammalian enucleated oocyte of same species, and implantation into uterus of surrogate mother for development |
| 04/10/2001 | US6214986 Antisense modulation of bcl-x expression |
| 04/10/2001 | US6214984 Nucleic acid coding for a linear heavy chain fragment including repeating variable and constant domains; recombinant production |
| 04/10/2001 | US6214983 Isolated nucleic acid molecules which encode SCP proteins |
| 04/10/2001 | US6214978 Antitumor and anticholesterol preparations containing a lipoteichoic acid from streptococcus |
| 04/10/2001 | US6214974 Internalizable cell binding component having biotin binding element conjugated to biotinylated nucleic acids or cytotoxic moieties such as gelonin, ricin, saporin, abrin, diptheria toxin and the like; gene therapy; drug delivery of toxins |
| 04/10/2001 | US6214973 Antibody light chain having variable region of defined amino acid sequence and human constant region; antitumor agents; anticarcinogenic agents; diagnosis |
| 04/10/2001 | US6214972 Human receptor of defined amino acid sequence; for recombinant preparation of membranes for screening agonists and antagonists; treatment of sleep disorders, allergic rhinitis, glaucoma, congestive heart failure; antiinflammatory agents |
| 04/10/2001 | US6214971 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/10/2001 | US6214970 Hepatitis E virus antigens and uses therefor |
| 04/10/2001 | US6214969 Luteinizing hormone releasing hormone analogs with cytotoxic moiety |
| 04/10/2001 | US6214968 Fibroblast stimulating growth factor 1 (FsF-1) and the early detection of fibrosis |
| 04/10/2001 | US6214863 Synergistic therapy for breast cancer consisting of taxol or taxotere and derivatives, with alkylating agent such as cyclophosphamide and anthracycline antibiotic (daunorubicin or doxorubicin); avoiding/ delaying multi-drug resistance |
| 04/10/2001 | US6214861 Enzyme inhibitor; viricides |
| 04/10/2001 | US6214841 Anticoagulants |
| 04/10/2001 | US6214805 Genes, gene signals, genomes rna strands and respiratory syncytial virus with promoters |
| 04/10/2001 | US6214802 Peritoneal dialysis fluid |
| 04/10/2001 | US6214800 Angiogenesis inhibitors |
| 04/10/2001 | US6214798 Polypeptides |
| 04/10/2001 | US6214797 Binding corticotropin releasing factor receptor 2 with binding affinity, increased production of adrenocorticotropic hormone and peptide with amino acid sequences |
| 04/10/2001 | US6214796 Administering a polypeptide growth factor for improved sensor motor deficit caused by injury |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214794 Proliferation or differentiation of nonpost mitotic neuronal cells with polypeptides |
| 04/10/2001 | US6214793 Method of treating tumors with thiodepsipeptide isolated from a marine actinomycete |
| 04/10/2001 | US6214791 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 04/10/2001 | US6214790 Neo-tryptophan |
| 04/10/2001 | US6214789 Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
| 04/10/2001 | US6214620 Inducible genetic suppression of cellular excitability |
| 04/10/2001 | US6214615 Cloned genes for human dopamine D2 receptors and cell lines expressing same |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214583 HCV genomic sequences for diagnostics and therapeutics |
| 04/10/2001 | US6214580 Nucleotide sequences coding binding protein associated with apoptosis; for detecting modulators of apoptosis; for treating cancers, sepsis, cachexia, autoimmune and viral diseases, inflammation, nervous system and liver disorders |
| 04/10/2001 | US6214569 Detecting therapeutic agents for treatment of nervous system disorders; incubate modulators and test compound, monitor reduction in the formation of peptide filaments in cells |
| 04/10/2001 | US6214562 Transcriptionally regualted G protein-coupled receptor |
| 04/10/2001 | US6214559 Methods of identifying inhibitors of binding of IL-13 to the IL-13 receptor chain |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214540 Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
| 04/10/2001 | US6214539 Synthetic antigen the detection of aids-related disease |
| 04/10/2001 | US6214535 Diagnosing cardiovascular disorders; obtain heart muscle tissue, detect hepatitis virus in tissues |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/10/2001 | US6214358 Isolated bermuda grass pollen protein allergens or antigenic or allergenic fragments thereof, useful for diagnosing and treating sensitivity in an individual to bermuda grass pollen allergens |
| 04/10/2001 | US6214356 Administering to the mammal a preparation comprising a portion of the amino acid sequence of mature adenylate cyclase of a second bordetella species; respiratory diseases, whooping cough |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214347 Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | US6214342 Method for increasing mean survival times of transplants with LFA-1-specific antibodies |
| 04/10/2001 | US6214340 Physiologically active substance sulphostin, process for producing the same, and use thereof |
| 04/10/2001 | US6214339 Di-enzymatic treatment of outer ear infection in dogs and cats |
| 04/10/2001 | US6214334 Integrating postmitotic human nt2n neurons (teratocarcinoma cell line (nt2) neurons) into the spinal cord of a mammal by implanting into the spinal cord |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | US6214316 Comprising cyclic peptide derivatives; kit for preparing a radiopharmaceutical preparation, comprising a sealed vial containing a predetermined quantity of the peptide |
| 04/10/2001 | US6214008 Biodegradable osteosynthesis implant |